Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Interleukin-17A Levels Vary in Relapsing-Remitting Multiple Sclerosis Patients in Association with Their Age, Treatment and the Time of Evolution of the Disease.
Integrin-linked kinase regulates oligodendrocyte cytoskeleton, growth cone, and adhesion dynamics.
Deficiency of the alkaline ceramidase ACER3 manifests in early childhood by progressive leukodystrophy.
Neuro-Behçet's disease, its mimickers and anti-TNF therapy: a case-based review.
Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitis.
Central adaptation after optic neuritis: Is the whole greater than the sum of its parts?
Evaluation of McDonald MRI criteria for dissemination in space in Korean patients with clinically isolated syndromes.
Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice.
Prevalence of neurological conditions across the continuum of care based on interRAI assessments.
FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway.
[Relationship between biochemical parameters of cerebrospinal fluid and the course of multiple sclerosis.]
[Teriflunomide is a new peroral disease-modifying drug for multiple sclerosis (a review)].
The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Effective communication at the point of multiple sclerosis diagnosis.
Insights into multiple sclerosis provided by non-coding RNAs: meeting summary from the symposium 'Non-coding RNAs in autoimmune disorders of the central nervous system' on 5 April 2013 in Warsaw, Poland.
Rapid parametric mapping of the longitudinal relaxation time t1 using two-dimensional variable flip angle magnetic resonance imaging at 1.5 tesla, 3 tesla, and 7 tesla.
Redefining Self: Patients' Decision Making About Treatment for Multiple Sclerosis.
Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis.
MRI pattern in asymptomatic natalizumab-associated PML.
Predictors of the physical impact of Multiple Sclerosis following community-based, exercise trial.
Are Natalizumab and Fingolimod Analogous Second-Line Options for the Treatment of Relapsing-Remitting Multiple Sclerosis? A Clinical Practice Observational Study.
Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items.
The right-to-die campaigner who won a key legal ruling.
'The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level - YES'.
Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a.

Pages